Key facts
as of Oct 2026- Developer of an artificial intelligence-powered point-of-care ultrasound system designed to empower clinicians with immediate diagnostics.
- AISAP is valued at approximately $22.5M as of Oct 2026 (last reported valuation).
- It has raised $26.0M; the latest was Accelerator/Incubator ($13.0M) in Jun 2025.
- Notable investors include ARC Innovation Center, Harel Insurance Investments & Financial Services, Interreg North-West Europe, Padeh Poriya Hospital, RISE (Accelerator) — 6 tracked in total.
- Status: Privately Held (backing).
Last reported valuation
LOW confidence$22.5M
AISAP's last reported valuation, Dec 2023. Nothing priced has surfaced since.
Free account
More of this page with a free account
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for AISAP
- ·The full record, as it builds
Create free account
No card required
Funding rounds
No rounds on record
No funding rounds for AISAP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
About AISAP
Developer of an artificial intelligence-powered point-of-care ultrasound system designed to empower clinicians with immediate diagnostics. The company offers a platform that streamlines ultrasound workflows and provides AI-driven interpretations by utilizing deep convolutional neural networks to analyze ultrasound images in real time, enabling medical professionals to make better clinical decisions and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Ramat Gan, Israel
- Founded
- 2022
- Employees
- 37
- Website
- aisap.ai/
- Ownership
- Privately Held (backing)